CellaVision AB (publ)
SSE:CEVI.ST
257 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 677.292 | 639.34 | 565.552 | 471.443 | 461.772 | 364.812 | 309.312 | 265.038 | 239.39 | 216.916 | 179.851 | 169.512 | 155.402 | 131.638 | 108.974 | 100.444 | 74.565 |
Cost of Revenue
| 214.251 | 201.023 | 173.25 | 158.402 | 125.038 | 93.946 | 86.092 | 76.102 | 65.157 | 71.814 | 67.225 | 59.456 | 53.991 | 44.082 | 32.486 | 36.941 | 29.312 |
Gross Profit
| 463.041 | 438.317 | 392.302 | 313.041 | 336.734 | 270.866 | 223.22 | 188.936 | 174.233 | 145.102 | 112.626 | 110.056 | 101.411 | 87.556 | 76.488 | 63.503 | 45.253 |
Gross Profit Ratio
| 0.684 | 0.686 | 0.694 | 0.664 | 0.729 | 0.742 | 0.722 | 0.713 | 0.728 | 0.669 | 0.626 | 0.649 | 0.653 | 0.665 | 0.702 | 0.632 | 0.607 |
Reseach & Development Expenses
| 83.333 | 88.553 | 64.248 | 51.253 | 56.417 | 39.253 | 26.786 | 29.239 | 27.124 | 22.765 | 20.683 | 21.435 | 21.407 | 17.336 | 12.058 | 11.898 | 11.137 |
General & Administrative Expenses
| 76.032 | 73.536 | 63.077 | 50.966 | 51.394 | 37.644 | 35.565 | 28.67 | 33.788 | 36.833 | 26.653 | 29.06 | 27.013 | 23.046 | 19.285 | 16.461 | 16.066 |
Selling & Marketing Expenses
| 136.624 | 117.962 | 102.246 | 100.549 | 102.348 | 82.362 | 69.977 | 56.859 | 47.851 | 42.691 | 39.344 | 38.859 | 35.281 | 33.637 | 30.443 | 21.748 | 15.135 |
SG&A
| 212.656 | 191.498 | 165.323 | 151.515 | 153.742 | 120.006 | 105.542 | 85.529 | 81.639 | 79.524 | 65.997 | 67.919 | 62.294 | 56.683 | 49.728 | 38.209 | 31.201 |
Other Expenses
| 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.09 | -0.411 | -0.075 | 0.012 | -0.227 |
Operating Expenses
| 295.989 | 280.051 | 229.571 | 202.768 | 210.159 | 159.259 | 132.328 | 114.768 | 108.763 | 102.289 | 86.68 | 89.354 | 83.611 | 73.608 | 61.711 | 50.119 | 42.111 |
Operating Income
| 167.052 | 158.266 | 162.733 | 110.273 | 126.576 | 111.607 | 90.892 | 74.168 | 65.47 | 42.813 | 25.946 | 20.702 | 17.8 | 13.948 | 14.777 | 13.384 | 3.142 |
Operating Income Ratio
| 0.247 | 0.248 | 0.288 | 0.234 | 0.274 | 0.306 | 0.294 | 0.28 | 0.273 | 0.197 | 0.144 | 0.122 | 0.115 | 0.106 | 0.136 | 0.133 | 0.042 |
Total Other Income Expenses Net
| -2.83 | -9.837 | -4.436 | 1.955 | 2.644 | 0.49 | -0.549 | 1.607 | 0.083 | 0.556 | -1.256 | -2.151 | 0.714 | -3.224 | -0.616 | -0.33 | -0.517 |
Income Before Tax
| 164.222 | 148.429 | 158.297 | 112.228 | 129.22 | 112.097 | 90.343 | 75.775 | 65.553 | 43.369 | 24.69 | 18.551 | 18.514 | 10.724 | 14.161 | 13.054 | 2.625 |
Income Before Tax Ratio
| 0.242 | 0.232 | 0.28 | 0.238 | 0.28 | 0.307 | 0.292 | 0.286 | 0.274 | 0.2 | 0.137 | 0.109 | 0.119 | 0.081 | 0.13 | 0.13 | 0.035 |
Income Tax Expense
| 33.913 | 30.094 | 32.958 | 22.748 | 30.048 | 23.408 | 20.62 | 15.975 | 12.731 | 11.904 | 5.758 | 12.1 | 3.881 | -27.625 | -13.559 | -12 | 0 |
Net Income
| 130.309 | 118.335 | 125.339 | 89.48 | 99.172 | 88.688 | 69.723 | 59.8 | 52.822 | 31.465 | 18.932 | 6.451 | 14.633 | 38.349 | 27.72 | 25.054 | 2.625 |
Net Income Ratio
| 0.192 | 0.185 | 0.222 | 0.19 | 0.215 | 0.243 | 0.225 | 0.226 | 0.221 | 0.145 | 0.105 | 0.038 | 0.094 | 0.291 | 0.254 | 0.249 | 0.035 |
EPS
| 5.46 | 4.96 | 5.25 | 3.75 | 4.16 | 3.72 | 2.92 | 2.51 | 2.22 | 1.32 | 0.79 | 0.27 | 0.61 | 1.61 | 1.16 | 1.05 | 0.11 |
EPS Diluted
| 5.46 | 4.96 | 5.25 | 3.75 | 4.16 | 3.72 | 2.92 | 2.51 | 2.22 | 1.32 | 0.79 | 0.27 | 0.61 | 1.61 | 1.16 | 1.05 | 0.11 |
EBITDA
| 199.815 | 190.866 | 193.6 | 146.812 | 150.87 | 119.063 | 98.951 | 84.073 | 73.135 | 56.875 | 33.998 | 26.677 | 18.913 | 13.948 | 14.792 | 13.747 | 3.402 |
EBITDA Ratio
| 0.295 | 0.299 | 0.342 | 0.311 | 0.327 | 0.326 | 0.32 | 0.317 | 0.306 | 0.262 | 0.189 | 0.157 | 0.122 | 0.106 | 0.136 | 0.137 | 0.046 |